Everest Medicines today announced that the first patient has been enrolled in a global multi-center Phase I clinical trial of…
Browsing: Clinical Trials
In the first half of 2025, the structural transformation of the pharmaceutical industry continued to deepen. Driven by favorable policies,…
Essex Bio-Technology Limited (Essex or the Group, HKG: 1061) is pleased to announce that a Biologics License Application (BLA) for…
On July 15 2025, to mark the successful secondary listing of China Medical System Holdings Limited (“CMS” or the “Group”)…
Technology Co-Developed by the U.S. Department of Veteran Affairs and Emory University Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the…
Hua Medicine (the Company, HKG: 2552) announced today that the Company presented the latest research results of dorzagliatin, its global…
Pneumonia is a form of acute respiratory infection, that is common in all age groups and can cause mild to…
– Offer price of S$0.25 per share is at an attractive premium of 61.3% over the last traded price being…
HighTide Therapeutics, Inc. (HKG: 2511), a clinical stage biopharmaceutical company specializing in the development of multifunctional multi-targeted therapies for chronic…
HighTide Therapeutics Announces HTD1801 Meets the Primary Endpoints in Two Phase 3 Clinical Trials in Patients with Type 2 Diabetes…
– Data from the proof-of-concept study showed berberine ursodeoxycholate was generally well tolerated and had beneficial therapeutic effect in improving…
Collaboration between Bascom Palmer Eye Institute and Provectus Biopharmaceuticals VisiRose, a clinical-stage biotechnology company, is introducing Rose Bengal Photodynamic Antimicrobial…
– Demonstrating Benefits of Berberine Ursodeoxycholate (HTD1801) HighTide Therapeutics, Inc. (HKG: 2511), a clinical stage biopharmaceutical company specializing in the…
– VLP-Polio Expected to Accelerate Development and Fill the Gap. CanSino Biologics Inc. (CanSinoBIO or the Company) has announced a…
GEN Pharmaceuticals (GENIL.IS), a leading Turkish pharmaceutical company, has announced the positive results of its Phase 2 clinical trial evaluating…
Highlighting Benefits of Berberine Ursodeoxycholate (HTD1801) HighTide Therapeutics, Inc. (HKG: 2511), a clinical stage biopharmaceutical company specializing in the development…
Hong Kong SAR | Germantown, MD, USA | Suzhou Biobay, China, Sirnaomics Ltd. (the Company, HKG: 2257, together with its…
Avance Clinical, the award-winning CRO for biotechs, is proud to announce the appointment of Jessica Han as Director, Asian Operations…
HighTide Therapeutics, Inc. (HKG: 2511), a clinical stage biopharmaceutical company specializing in the development of multi-targeted therapies for chronic liver…
HighTide Therapeutics, Inc. (HKG: 2511), a clinical stage biopharmaceutical company specializing in the development of multi-targeted therapies for chronic liver…